Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Yasuko Iwakiri

Clin Mol Hepatol. 2015;21(4):319-325. Published online December 24, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.4.319

View: 12155 Download: 227 Web of Science: 69 Crossref: 74

Yeon Seok Seo, Vijay H. Shah

Clin Mol Hepatol. 2012;18(4):337-346. Published online December 21, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.4.337

View: 11385 Download: 191 Crossref: 84

Kyu Won Chung

Clin Mol Hepatol. 2002;8(4):505-514. Published online January 1, 1970

View: 2378 Download: 12

Jin Mo Yang

Clin Mol Hepatol. 2001;7(2):216-219. Published online January 1, 2000

View: 1907 Download: 14

1 |

Viewed By 5145	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5010	MAFLD: How is it different from NAFLD?
Viewed By 4915	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3643	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3583	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 67	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 51	MAFLD: How is it different from NAFLD?

Search